Chatterjee, S. S., Linares, J. F., Cid-Diaz, T., Duran, A., Khan, M. I. K., Osrodek, M., . . . Diaz-Meco, M. T. Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer. Nature Portfolio.
Chicago Style (17th ed.) CitationChatterjee, Shankha S., et al. Increased Translation Driven by Non-canonical EZH2 Creates a Synthetic Vulnerability in Enzalutamide-resistant Prostate Cancer. Nature Portfolio.
MLA (9th ed.) CitationChatterjee, Shankha S., et al. Increased Translation Driven by Non-canonical EZH2 Creates a Synthetic Vulnerability in Enzalutamide-resistant Prostate Cancer. Nature Portfolio.
Warning: These citations may not always be 100% accurate.